Categories AlphaGraphs, Technology, U.S. Markets News
Micron stock spikes even as semiconductor recovery gathers steam
The steady improvement in the performance of Micron (MU) shares since the beginning of the year, after staying in the bear market territory for several months, could be seen as an indication that the pricing pressure in the semiconductor industry is finally easing. Though the company was cautious while issuing its third-quarter guidance, which fell short of expectations, it hinted at getting back on track by the second half of the year.
Extending the ongoing uptrend, the stock rose around 5% in early trading Friday, adding to the speculation that the demand for DRAM chips is improving. Earlier, unconfirmed reports suggested that Amazon (AMZN) is looking for alternatives for bulk supply of chips after its tie-up with the current supplier ran into trouble.
The stock rose around 5% Friday, adding to the speculation that the demand for DRAM chips is improving
Micron will continue to be a hot pick in the coming weeks as it may take some time for memory prices to finally bottom out. Considering the company’s dominance in the DRAM-NAND memory market, the stock will gather strength once the market bounces back later this year. As of now, there is a great deal of optimism about the management’s claims of a rebound in the second half, especially when it comes after the company’s dismal performance in the second quarter.
This week, RBC Capital started the coverage of Micron with an impressive outperform rating, with the analyst echoing Micron’s view that chip prices are set to recover later this year. At $50, RBC’s price target on the stock is 26% above the current level.
In the second quarter, all the key business segments registered negative growth, resulting in a 21% fall in Micron’s revenues. Hurt by the poor top-line performance, the company’s profit nearly halved year-on-year. Though the outcome was still better than the estimates, the management guided the third-quarter numbers below consensus.
Micron shares fell 21% in the past twelve months. After slipping to a one-year low in December last year, the stock rose steadily and has stayed on the recovery path, hovering near the $40-mark.
Get access to timely and accurate verbatim transcripts that are published within hours of the event
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on